Varenicline Tablet, Film Coated
Product Images NDC 49884-156

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 49884-156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-stru (Varenicline Tablets 1)

Chemical structure of varenicline tartrate, the active ingredient in Varenicline tablets. The diagram shows molecular components including rings and functional groups consistent with varenicline and tartrate ions.*

FDA Label Image

Figure-1 (Varenicline Tablets 2)

A bar chart displaying four studies comparing different treatments involving varenicline and placebo. The chart shows percentage values on the vertical axis, with distinct bars representing Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and placebo groups. Each study groups these treatments side-by-side with error bars to indicate variability or confidence intervals.*

FDA Label Image

Figure-2 (Varenicline Tablets 3)

A bar chart comparing percentages across four clinical studies labeled STUDY 2 to STUDY 5. The chart shows groups including Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and Placebo. Error bars indicate variability for each group. Percent values range from 0% to 35% on the y-axis. The chart illustrates comparative outcomes for these treatments in the studies.*

FDA Label Image

Figure-3 (Varenicline Tablets 4)

A line graph comparing the percentage of continuous abstinent subjects over nontreatment follow-up weeks between Varenicline 1.0 mg twice daily and placebo groups. The y-axis shows % continuous abstinent and the x-axis shows follow-up weeks with sample sizes. The graph shows Varenicline maintaining a higher abstinence rate over time versus placebo.*

FDA Label Image

Label-56's Count (Varenicline Tablets 5)

Varenicline Tablets 0.5 mg film-coated oral tablets label showing 56 tablets per bottle. The label includes dosage information, pharmacist dispensing instructions, storage conditions, and manufacturer details by Par Formulations Private Limited. The National Drug Code (NDC) 49884-155-76 is displayed, along with the Par Pharmaceutical logo.*

FDA Label Image

Label-56's Count (Varenicline Tablets 6)

Varenicline Tablets 1 mg film-coated tablets label from Par Pharmaceutical showing a package of 56 tablets. It includes dosage information, pharmacist dispensing instructions, and storage conditions. The label lists varenicline tartrate equivalent to 1 mg varenicline free base per tablet, and contains barcodes and manufacturer details.*

FDA Label Image

Starting Month Box (Varenicline Tablets 7)

Packaging label for Varenicline Tablets Starting Month Box by Par Pharmaceutical. The box contains film-coated oral tablets in two dosages: 0.5 mg for the starting week and 1 mg for the continuing weeks, totaling 53 tablets (11 tablets at 0.5 mg and 42 tablets at 1 mg). The label includes dosage instructions, storage conditions, manufacturer details, and a barcode. The product is prescription only.*

FDA Label Image

Starting Pack (Varenicline Tablets 8)

Varenicline Tablets Starting Pack packaging label showing blister cards for two dosage strengths: 0.5 mg and 1 mg film-coated tablets. The label includes instructions to use the green blister card first and advises pharmacists to provide a Medication Guide. Distributed by Par Pharmaceutical and manufactured by Par Formulations Private Limited. Includes NDC 49884-944-99, barcode, and product details on a multi-colored blister card design.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.